AwardTape · Defense awards · Medical · Drugs and biologicals · SPE2D325F345L
SPE2D325F345L: $314 delivery order to Hikma Pharmaceuticals USA Inc
Hikma Pharmaceuticals USA Inc holds a delivery order from Defense Logistics Agency with $314 obligated since Oct 2023, against a ceiling of $314. Latest action Aug 25, 2025.
4569234694 etomidate 40 mg/20 ml vial 20ml
| PIID | SPE2D325F345L |
|---|---|
| Type | delivery order |
| Parent award | SPE2D020D0006 |
| Company | Hikma Pharmaceuticals USA Inc |
| Agency | Defense Logistics Agency |
| Contracting office | DLA TROOP SUPPORT |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325411 MEDICINAL AND BOTANICAL MANUFACTURING |
| Obligated since Oct 2023 | $314 |
| Total obligated (lifetime) | $314 |
| Ceiling (base and all options) | $314 |
| Base date | Aug 25, 2025 |
| Latest action | Aug 25, 2025 |
| End date | Aug 28, 2025 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Full and open competition |
| Place of performance | NJ |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial